Clinical Trial Update: Endothelial Modulation for Angiogenic Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating endothelial modulation for angiogenic therapy in coronary artery disease has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED